Abstract: Disclosed is a compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: X1-L-X2 wherein L is a linking moiety comprising an enone; and X1 and X2 are each independently an optionally-substituted N-heterocycle. Also disclosed are method for treating pulmonary conditions and other organ or system conditions with the compounds.
Type:
Application
Filed:
May 9, 2014
Publication date:
March 31, 2016
Applicants:
University of Pittsburgh - of the Commonwealth System of Higher Education, The United States Govemment as represented by the Department of Veterans Affairs